Horizant
- Product NDC
- 53451-0101
- 11-digit product format
- 534510101
- Labeler code
- 53451
- Product ID
- 53451-0101_33da187f-72d1-daa5-e063-6394a90a66b1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- gabapentin enacarbil
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Application
- NDA022399
- Marketing category
- NDA
- Marketing start
- 2013-05-01
- Substance
- GABAPENTIN ENACARBIL
- Active strength
- 600 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Horizant
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GABAPENTIN ENACARBIL | 600 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 75OCL1SPBQ |
| Rxcui | 1101338, 1101339, 1482820, 1482821 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53451-0101-1 | Horizant | 30 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 30 | | 16 |
| 53451-0101-9 | Horizant | 5 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 5 | | 16 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| GABAPENTIN ENACARBIL | ACTIVE INGREDIENT | 75OCL1SPBQ | HORIZANT (GABAPENTIN ENACARBIL) TABLET, EXTENDED RELEASE [XENOPORT INC.] | 5 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | HORIZANT (GABAPENTIN ENACARBIL) TABLET, EXTENDED RELEASE [XENOPORT INC.] | 5 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | HORIZANT (GABAPENTIN ENACARBIL) TABLET, EXTENDED RELEASE [XENOPORT INC.] | 5 | |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | INACTIVE INGREDIENT | O7TSZ97GEP | HORIZANT (GABAPENTIN ENACARBIL) TABLET, EXTENDED RELEASE [XENOPORT INC.] | 5 | |
| GLYCERYL BEHENATE | INACTIVE INGREDIENT | R8WTH25YS2 | HORIZANT (GABAPENTIN ENACARBIL) TABLET, EXTENDED RELEASE [XENOPORT INC.] | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | HORIZANT (GABAPENTIN ENACARBIL) TABLET, EXTENDED RELEASE [XENOPORT INC.] | 5 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | HORIZANT (GABAPENTIN ENACARBIL) TABLET, EXTENDED RELEASE [XENOPORT INC.] | 5 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | HORIZANT (GABAPENTIN ENACARBIL) TABLET, EXTENDED RELEASE [XENOPORT INC.] | 5 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53451-0101 | HORIZANT (GABAPENTIN ENACARBIL) TABLET, EXTENDED RELEASE [AZURITY PHARMACEUTICALS, INC. (FORMERLY ARBOR PHARMACEUTICALS)] | 16 | Current NDC, Legacy NDC, 2 package rows | 20250507_4c486fc7-c8c4-4c6c-b30c-366dabaeaadd.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53451-0101-1 | 53451010101 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53451-0101-1) | 2013-05-01 | 0000-00-00 | No | No | Current |
| 53451-0101-9 | 53451010109 | 5 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53451-0101-9) | 2013-05-01 | 0000-00-00 | No | No | Current |